Hospitals, insurers want rebate rule changed to keep pharma honest

Modern Healthcare: Insurers and hospitals want the CMS to amend its proposed rule eliminating the safe harbor for Medicare Part D and Medicaid managed-care drug rebates to include new requirements for drugmakers.

In comments on the proposed rule, several companies and groups expressed concern that the change eliminating the safe harbor for rebates and replacing it with a safe harbor for point-of-sale discounts won't force drugmakers to lower prices. In addition they said implementing the changes in January 2020 would be too soon.

Read article